TherapeuticsMD Inc. buy stratec
Start price
26.10.18
/
50%
€242.64
Target price
04.11.21
€200.00
Performance (%)
-86.61%
End price
05.11.21
€32.50
Summary
This prediction ended on 05.11.21 with a price of €32.50. The BUY prediction by stratec for TherapeuticsMD Inc. performed very badly with a performance of -86.61%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TherapeuticsMD Inc. | 9.286% | 9.286% | 30.769% | -75.323% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by stratec for this prediction
In the thread Therapeuticsmd Inc. diskutieren
stratec stimmt der Buy-Einschätzung der institutionellen Analysten zu
TherapeuticsMD announces that it is discussing labeling with the FDA related to hormone therapy candidate TX-001HR.
The agency's action date for its proposed use for treating moderate-to-severe vasomotor symptoms due to menopause is October 28, but a decision may be announced today.
Kursziel geändert auf 4,0
In the thread Trading Therapeuticsmd Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten